Synchrotron Radiation-Based FTIR Microspectroscopy Study of 6-Hydroxydopamine Induced Parkinson’s Disease Cell Model

[1] Dumas P, Sockalingum G D, Sule-Suso J. Trends in Biotechnology, 2006, 25(1): 40.

[2] Miller L M, Dumas P. Biochimica et Biophysica Acta, 2006, 1758: 846.

[4] Prolla T A, Mattson M P. Trends Neurosci, 2001, 24(11 Suppl): S21.

[5] Hillion J M, Canals M, Torvinen M, et al. J. Biol. Chem., 2002. 277(20): 18091.

[6] Heikkila R E, Sonsalla P K, Duvoisin R C. Neuromethods, 1989. 12: 351.

[7] Petibois C, Deleris G. Trends Biotechnology, 2006, 24(10): 455.

[8] Petibois C, Deleris G. Cell Biol. Int., 2005, 29(8): 709.

[9] Chen C T, Green J T, Orr S K, et al. Prostaglandins Leukot Essent Fatty Acids, 2008. 79(3-5): 85.

[10] Darios F, Davletov B. Nature, 2006, 440(7085): 813.

[11] Klivenyi P, Beal M F, Ferrante R J, et al. J. Neurochem., 1998, 71(6): 2634.

[12] Farooqui A A, Horrocks L A. Cell Mol. Neurobiol., 1998. 18(6): 599.

[13] Bandekar J. Biochim. Biophys. Acta, 1992, 1120(2): 123.

[14] Krimm S, Bandekar J. Adv. Protein Chem., 1986, 38: 181.

[15] Ross C A, Poirier M A. Nat. Med., 2004, 10(Suppl): S10.

[16] Welzel A T, Walsh D M. Ir J. Med. Sci., 2011. 180(1): 15.

[17] Sahu R K, Mordechai S, Manor E. Biopolymers, 2008, 89(11): 993.

[18] Perumal A S, Gopal V B, Tordzro W K, et al. Brain Res. Bull., 1992. 29(5): 699.